These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 38854798)
1. Role of the transient receptor potential melastatin 4 in inhibition effect of arsenic trioxide on the tumor biological features of colorectal cancer cell. Gao Z; Lv J; Tong TT; Zhang K; Han YX; Zhao Y; Shen MM; Liu Y; Ban T; Sun Y PeerJ; 2024; 12():e17559. PubMed ID: 38854798 [TBL] [Abstract][Full Text] [Related]
2. Transient receptor potential melastatin 4 contributes to early-stage endothelial injury induced by arsenic trioxide. Yu CX; Zhang YY; Wu XY; Tang HX; Liang XQ; Xue ZM; Xue YD; Li J; Zhu H; Huo R; Ban T Toxicol Lett; 2019 Sep; 312():98-108. PubMed ID: 31054354 [TBL] [Abstract][Full Text] [Related]
3. TRPM4 is highly expressed in human colorectal tumor buds and contributes to proliferation, cell cycle, and invasion of colorectal cancer cells. Kappel S; Stokłosa P; Hauert B; Ross-Kaschitza D; Borgström A; Baur R; Galván JA; Zlobec I; Peinelt C Mol Oncol; 2019 Nov; 13(11):2393-2405. PubMed ID: 31441200 [TBL] [Abstract][Full Text] [Related]
4. Arsenic Trioxide Inhibits Cell Growth and Invasion via Down- Regulation of Skp2 in Pancreatic Cancer Cells. Gao JK; Wang LX; Long B; Ye XT; Su JN; Yin XY; Zhou XX; Wang ZW Asian Pac J Cancer Prev; 2015; 16(9):3805-10. PubMed ID: 25987041 [TBL] [Abstract][Full Text] [Related]
5. Arsenic trioxide suppresses cell growth and migration via inhibition of miR-27a in breast cancer cells. Zhang S; Ma C; Pang H; Zeng F; Cheng L; Fang B; Ma J; Shi Y; Hong H; Chen J; Wang Z; Xia J Biochem Biophys Res Commun; 2016 Jan; 469(1):55-61. PubMed ID: 26592661 [TBL] [Abstract][Full Text] [Related]
6. TG-interacting factor transcriptionally induced by AKT/FOXO3A is a negative regulator that antagonizes arsenic trioxide-induced cancer cell apoptosis. Liu ZM; Tseng HY; Cheng YL; Yeh BW; Wu WJ; Huang HS Toxicol Appl Pharmacol; 2015 May; 285(1):41-50. PubMed ID: 25791921 [TBL] [Abstract][Full Text] [Related]
7. Arsenic Trioxide Induces Apoptosis and Incapacitates Proliferation and Invasive Properties of U87MG Glioblastoma Cells through a Possible NF-κB-Mediated Mechanism. Ghaffari SH; Yousefi M; Dizaji MZ; Momeny M; Bashash D; Zekri A; Alimoghaddam K; Ghavamzadeh A Asian Pac J Cancer Prev; 2016; 17(3):1553-64. PubMed ID: 27039805 [TBL] [Abstract][Full Text] [Related]
8. Combination effects of arsenic trioxide and fibroblast growth factor receptor inhibitor in squamous cell lung carcinoma. Lam SK; Leung LL; Li YY; Zheng CY; Ho JC Lung Cancer; 2016 Nov; 101():111-119. PubMed ID: 27794399 [TBL] [Abstract][Full Text] [Related]
9. Combination of canstatin and arsenic trioxide suppresses the development of hepatocellular carcinoma. Zhang F; Duan J; Song H; Yang L; Zhou M; Wang X Drug Dev Res; 2021 May; 82(3):430-439. PubMed ID: 33244794 [TBL] [Abstract][Full Text] [Related]
10. Arsenic trioxide inhibits cell growth and induces apoptosis through inactivation of notch signaling pathway in breast cancer. Xia J; Li Y; Yang Q; Mei C; Chen Z; Bao B; Ahmad A; Miele L; Sarkar FH; Wang Z Int J Mol Sci; 2012; 13(8):9627-9641. PubMed ID: 22949821 [TBL] [Abstract][Full Text] [Related]
11. Transient Receptor Potential Melastatin 4 (TRPM4) Contributes to High Salt Diet-Mediated Early-Stage Endothelial Injury. Ding XQ; Ban T; Liu ZY; Lou J; Tang LL; Wang JX; Chu WF; Zhao D; Song BL; Zhang ZR Cell Physiol Biochem; 2017; 41(2):835-848. PubMed ID: 28214884 [TBL] [Abstract][Full Text] [Related]
12. Arsenic trioxide prevents radiation-enhanced tumor invasiveness and inhibits matrix metalloproteinase-9 through downregulation of nuclear factor kappaB. Wei LH; Lai KP; Chen CA; Cheng CH; Huang YJ; Chou CH; Kuo ML; Hsieh CY Oncogene; 2005 Jan; 24(3):390-8. PubMed ID: 15531921 [TBL] [Abstract][Full Text] [Related]
13. Downregulation of B7-H4 in the MHCC97-H hepatocellular carcinoma cell line by arsenic trioxide. Cui L; Gao B; Cao Z; Chen X; Zhang S; Zhang W Mol Med Rep; 2016 Mar; 13(3):2032-8. PubMed ID: 26781180 [TBL] [Abstract][Full Text] [Related]
14. Alteration in miRNA gene expression pattern in acute promyelocytic leukemia cell induced by arsenic trioxide: a possible mechanism to explain arsenic multi-target action. Ghaffari SH; Bashash D; Dizaji MZ; Ghavamzadeh A; Alimoghaddam K Tumour Biol; 2012 Feb; 33(1):157-72. PubMed ID: 22072212 [TBL] [Abstract][Full Text] [Related]
15. Cryptotanshinone enhances the effect of Arsenic trioxide in treating liver cancer cell by inducing apoptosis through downregulating phosphorylated- STAT3 in vitro and in vivo. Shen L; Zhang G; Lou Z; Xu G; Zhang G BMC Complement Altern Med; 2017 Feb; 17(1):106. PubMed ID: 28187727 [TBL] [Abstract][Full Text] [Related]
16. Arsenic trioxide exerts a double effect on osteoblast growth in vitro. Xu WX; Liu Y; Liu SZ; Zhang Y; Qiao GF; Yan J Environ Toxicol Pharmacol; 2014 Sep; 38(2):412-9. PubMed ID: 25128771 [TBL] [Abstract][Full Text] [Related]
17. Increased growth-inhibitory and cytotoxic activity of arsenic trioxide in head and neck carcinoma cells with functional p53 deficiency and resistance to EGFR blockade. Boyko-Fabian M; Niehr F; Distel L; Budach V; Tinhofer I PLoS One; 2014; 9(6):e98867. PubMed ID: 24927258 [TBL] [Abstract][Full Text] [Related]
18. Arsenic trioxide inhibits CXCR4-mediated metastasis by interfering miR-520h/PP2A/NF-κB signaling in cervical cancer. Chang YW; Chen MW; Chiu CF; Hong CC; Cheng CC; Hsiao M; Chen CA; Wei LH; Su JL Ann Surg Oncol; 2014 Dec; 21 Suppl 4():S687-95. PubMed ID: 25047463 [TBL] [Abstract][Full Text] [Related]
19. Differential anticancer activities of arsenic trioxide on head and neck cancer cells with different human papillomavirus status. Du S; Liu K; Gao P; Li Z; Zheng J Life Sci; 2018 Nov; 212():182-193. PubMed ID: 30243648 [TBL] [Abstract][Full Text] [Related]
20. Arsenic trioxide attenuates STAT-3 activity and epithelial-mesenchymal transition through induction of SHP-1 in gastric cancer cells. Kim SH; Yoo HS; Joo MK; Kim T; Park JJ; Lee BJ; Chun HJ; Lee SW; Bak YT BMC Cancer; 2018 Feb; 18(1):150. PubMed ID: 29409467 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]